Article
Histone acetylation gene‐based biomarkers as novel markers of the immune microenvironment in glioblastoma
25 Apr 2023
Abstract excerpt
BACKGROUND: Glioblastoma (GBM) is a primary malignant tumour with high intracranial morbidity, high malignancy and poor prognosis. Abnormal changes in histone acetylation are closely related to the occurrence and development of cancer. However, there is still a lack of systematic research on histone acetylation in GBM. METHODS: Whole-transcriptome sequencing data and clinical data of GBM patients were obtained...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
